Key facts
- This page summarizes Ming Yan's Form 4 filing for Cytek Biosciences, Inc. (CTKB).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 16 Jun 2026, 16:59.
Ming Yan - 12 Jun 2026 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)
- Reporting relationship
- CHIEF TECHNOLOGY OFFICER, Director
- Issuer ticker
- CTKB
- Reported as of
- 12 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Jun 2026, 16:59:02 UTC
- Prior SEC filing
- 20 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Valerie Barnett, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ming Yan filed Form 4 for Cytek Biosciences, Inc. (CTKB) on 16 Jun 2026.
Change
- Previous filing in this sequence was filed on 20 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001874041
Primary reporting owner
Yan Ming
- Relationship
- CHIEF TECHNOLOGY OFFICER, Director
- Address
- C/O CYTEK BIOSCIENCES, INC., 47215 LAKEVIEW BOULEVARD, FREMONT
- Signature
- /s/ Valerie Barnett, Attorney-in-Fact
- Signature date
- 16 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CTKB
transaction
Common Stock
Gift
- Transaction value
- Shares
- -135,892
- Change %
- -2.8%
- Price
- $0.000000*
- Shares after
- 4,796,688
- Date
- 12 Jun 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.